BusinessJagsonpal Pharma to Acquire Group Pharmaceuticals' Wellness Portfolio for Rs 46.7 Crore
Jagsonpal Pharmaceuticals, based in New Delhi, has signed a Business Transfer Agreement with Group Pharmaceuticals to acquire its wellness portfolio. The acquisition will be conducted on a going-concern basis through a slump sale, with the deal valued at up to Rs 46.7 crore. This strategic move aims to expand Jagsonpal's product offerings in the wellness segment.
Business Medical Dialogues·14h ago·New Delhi



